As it progresses, bone pain, anemia, kidney dysfunction, and infections may occur. Pdf myeloma bone disease mbd is a devastating complication of multiple myeloma mm. Complications of multiple myeloma include acute renal failure, anemia, bone damage, intractable pain, and recurrent infections. Jatin shah, md, explains that there is no clear reason for why patients develop multiple myeloma, and so theres no clear risk factor. Learn more about multiple myeloma s stages and the systems that determine these phases of the disease. Scientists still do not know exactly what causes most cases of multiple myeloma. Multiple myeloma is a rare cancer that affects bone marrow.
It is difficult to diagnose multiple myeloma early. Multiple myeloma plasma cells, which originate from postfollicular b cells, are characterised by complex chromosomal aberrations. Multiple myeloma and related disorders pathophysiology of. Multiple myeloma causes, risk factors, and prevention. Multiple myeloma mm, which accounts for approximately 10% of all haematological malignancies, is a clonal, late b cell malignancy in which plasma cells pc accumulate in the bone marrow bm. It is the second most commonly diagnosed hematologic malignancy with an annual incidence and prevalence in the united states of approximately 15,000 and approximately 45,000, respectively. Bone is one of the most common sites of complication. February 28, 2018 signs and symptoms of multiple myeloma some patients with multiple myeloma have no. Multiple myeloma is a cancer that forms in a type of white blood cell called a plasma cell. Oct 01, 2008 fore, the multiple myeloma process leads to an exces sive m protein level, which causes hyperviscosity. David roodman multiple myeloma mm is a plasma cell. Multiple myeloma is a monoclonal malignancy of plasma cells in the bone marrow resulting in their overproduction and production of large quantities of functionless immunoglobulins.
The underlying pathophysiologic phenomena of the clinical features include suppression of humoral and cellmediated immunity, elevation of il6, abnormalities of the bone marrow microenvironment, and increased. Cancerous plasma cells are known as multiple myeloma cells. Multiple myeloma is a malignant or cancerous disease of the monoclonal plasma cells in the bone marrow. Obd or osteopenia is one of the defining features of multiple myeloma mm. Multiple myeloma and related disorders pathophysiology.
It is characterised by a clonal population of bone marrow plasma cells which secrete a monoclonal paraprotein or an immunoglobulin free light chain flc figure 1a, b. Multiple myeloma mm, also known as symptomatic plasma cell myeloma, is a plasma cell malignancy. Multiple myeloma mm is a malignant plasma cell disorder that accounts for approximately 10 percent of all hematologic malignancies. Multiple myeloma mm is a plasma cell malignancy in which monoclonal plasma cells proliferate in bone marrow, resulting in an overabundance of monoclonal paraprotein m protein, destruction of. Multiple myeloma, also known as myeloma, is the second most common blood cancer in the united states. Nov 20, 2020 multiple myeloma sometimes referred to as myeloma is a rare type of blood cancer that involves the abnormal growth of plasma cellsa type of white blood cellthat accumulate uncontrollably in the bone marrow. Multiple myeloma is a type of cancer that occurs when plasma cells become cancerous and produce plasmacytoma. Detection of abnormal protein in serum and urine increased abnormal plasma cells in bone marrow 10% plus crab or flc ratio 100, or greater than 60% associated symptoms. Bone destruction in mm results from increased osteoclast formation and activity that occur in close proximity to myeloma cells.
Multiple myeloma affects slightly more men than women. Multiple myeloma almost always starts out as mgus, so having this condition increases your risk. However, histomorphometric studies have demonstrated that mm patients with osteolytic bone lesions have lower numbers of osteoblasts and decreased bone formation. Healthy plasma cells help you fight infections by making antibodies that recognize and attack germs. Multiple myeloma can cause kidney problems as well as bone lesions and hypercalcemia. Multiple myeloma mm is a debilitating malignancy that is part of a spectrum of diseases ranging from monoclonal gammopathy of unknown significance mgus to plasma cell leukemia. Complications may include amyloidosis the cause of multiple myeloma is unknown. Multiple myeloma cells also produce abnormal light chain proteins. Multiple myeloma is the second most common type of blood cancer after leukemia. Common manifestations include lytic lesions in bones causing pain, andor fractures, renal insufficiency, hypercalcemia, anemia, and recurrent infections. In 2015, an estimated 28,850 new cases of multiple myeloma were diagnosed in the united states, and the disease caused more than 11,000 deaths. Myeloma cells inhibit your bodys ability to fight infections. Multiple myeloma mm is a plasma cell malignancy characterized by a high capacity to induce osteolytic bone lesions. More than 80% of mm patients suffer from destructive bony lesions.
In multiple myeloma, collections of abnormal plasma cells accumulate in the bone marrow, where they interfere with the production of normal blood cells. It is an incurable disease and the cause of about 20 percent of deaths from hematologic malignancy and 2 percent of deaths from all cancers. Myeloma ig heavy chain v region sequences reveal prior antigenic. The multiple myelomainduced bone destruction is a result of the increased activity of osteoclasts that occurs adjacent to multiple myeloma cells. New role of hypoxia in pathophysiology of multiple myeloma. What cancer patients, their families, and caregivers need to know about the coronavirus.
In multiple myeloma, cancerous plasma cells accumulate in the bone marrow and crowd out healthy blood cells. Scribd is the worlds largest social reading and publishing site. Other characteristics are the presence of monoclonal antibodies in the serum and urine, kidney failure, and osteopenia hideshima et al. Monoclonal myeloma plasma cells proliferate and overproduce m protein abnormal igg, igm, or iga, or rarely ige or igd. The bone marrow produces red blood cells, which carry oxygen throughout the body. Multiple myeloma mm arises from postgerminal b cells in the lymph node, with immunoglobulin ig gene rearrangement, extensive somatic hypermutation, and class switching of immunoglobulin heavy chain igh genes, suggesting that the malignant plasma cells have undergone antigen selection. Multiple myeloma mm is a neoplasm of postgerminal center, terminally differentiated b cells. Subscribe to our free newsletters to receive latest health news and alerts to your email inbox. Multiple myeloma is the secondmost prevalent blood cancer 10% after nonhodgkins lymphoma. Furthermore, some patients even within these precursor states are at higher risk of developing the disease or at higher risk of faster progression.
In 2015, an estimated 28,850 new cases of multiple myeloma were diagnosed in the united states, and the disease caused more. It will help you learn medical terms and concepts you may not have encountered before. With the duriesalmon staging system, the stage of multiple myeloma is determined based on four measurements. As the multiple myeloma communitys most trusted source of information, the mmrf supports patients from the point of diagnosis throughout the course of the. Dec 01, 2007 recently the biologic mechanism involved in the imbalance between osteoclast activation and osteoblast inhibition induced by multiple myeloma cells has begun to be clarified. Multiple myeloma symptoms, pathophysiology and diagnosis. Multiple myeloma is a common malignancy in patients above 40 70% of cases are diagnosed between ages 50 and 70 with a median age of diagnosis being 69 years with a male predilection m.
With multiple myeloma, few cases are linked to risk factors that can be avoided, so there is no known way to prevent most multiple myelomas from developing. Learn more about the symptoms, causes, diagnosis, risk factors, and treatment of multiple myeloma. Multiple myeloma occurs when patients have more than one plasmacytoma. Multiple myeloma is a monoclonal malignancy of plasma cells in the bone marrow resulting in their overproduction and production of large quantities of functionless immunoglobulins it is the second most common cancer affecting older people. Most laboratory tests for multiple myeloma provide indirect information about the amount of tumor present, by measuring proteins that are secreted by the tumor into the blood andor the urine. Multiple myeloma stages international myeloma foundation. Multiple myeloma mm is a hematological neoplasia with uncontrolled proliferation and accumulation of plasma cells in the bone marrow bm microenvironment hideshima et al. Multiple myeloma is a hematological malignancy characterized by the accumulation of malignant plasma cells in the bone marrow and in the majority of cases, findings of monoclonal immunoglobulins in the blood.
Whether you or someone you love has cancer, knowing what to expect can. The american society of clinical oncology notes that its relatively uncommon in the united states, affecting about one in every 2 people. Pdl1pd1 pathway in the pathophysiology of multiple. Multiple myeloma mm, also known as plasma cell myeloma and simply myeloma, is a cancer of plasma cells, a type of white blood cell that normally produces antibodies. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related. It accounts for 1% of all malignancies and 10% of all hematological disease 12. With a mean survival from diagnosis of 45 years, there are between 20 000 and 30 000 multiple myeloma patients at any time in the uk. Multiple myeloma may be diagnosed sooner in those people than those who did not have mgus or a solitary plasmacytoma. Among the earliest genetic events are translocations of the immunoglobulin heavychain gene.
Multiple myeloma can also affect your bones, leading to bone pain, thinning bones and broken. Pathophysiology and diagnosis of multiple myeloma youtube. Osteolytic lesions develop in nearly 90% of patients with mm. Multiple myeloma characterized by waldenstroms proliferation of a single clone macroglobulinemia of plasma cells amyloidosis plasma cell leukemia major criteria i. As the name implies, at diagnosis, multiple myeloma typically involves multiple bones of the axial skeleton, particularly the vertebrae, skull, proximal long bones of the extremities, and ribs. Myeloma is called multiple because it frequently involves multiple areas in the body. New insights into the pathophysiology of multiple myeloma. Feb 27, 2019 please use one of the following formats to cite this article in your essay, paper or report. Pathobiology and diagnosis of multiple myeloma sciencedirect. Multiple myeloma is the second most common blood cancer after nonhodgkins lymphoma. Whether you or a loved one are worried about developing multiple myeloma, have just been diagnosed, are going through treatment, or are trying to stay well after treatment, this detailed guide can help you find the answers you need. Multiple myeloma mm is a plasma cell malignancy in which monoclonal plasma cells proliferate in bone marrow, resulting in an. Multiple myeloma is a cancer of plasma cells, which are normally responsible for producing antibodies. Pathophysiology the pathological and clinical features of myeloma are due to.
It represents approximately 1% of all cancers and just under 2% of all cancer deaths. Multiple myeloma is a hematologic malignancy characterized by the clonal proliferation of plasma cells in the bone marrow and, usually, the presence of a monoclonal ig in the blood andor urine. Patients with multiple myeloma are vulnerable to the nephrotoxic effects of chemotherapy medications and the imaging contrast exposure needed to monitor disease progress and treatment efficacy. Multiple myeloma is a cancer of plasma cells that produce monoclonal immunoglobulin and invade and destroy adjacent bone tissue. Aug 01, 2019 multiple myeloma has precursor states before becoming active myeloma. The myeloma cells are usually only found inside the bone marrow. Dec 15, 2006 multiple myeloma mm is a plasma cell malignancy characterized by a high capacity to induce osteolytic bone lesions. It is the second most common cancer affecting older people. Multiple myeloma is a rare blood cancer of the plasma cells, a type of white blood cell which originates in the bone marrow. Duriesalmon staging system is an older staging system that is still sometimes used. Oct 09, 2019 introduction multiple myeloma mm is a malignancy of plasma cells which represents about 2% of all new cancer cases in the united kingdom. The patient handbook focuses on the questions and decisions that a newly diagnosed patient faces. The multiple myeloma induced bone destruction is a result of the increased activity of osteoclasts that occurs adjacent to multiple myeloma cells. Myeloma also called multiple myeloma is a cancer that forms in white blood cells.
The presenting features of multiple myeloma are nonspecific. More than 80% of mm patients suffer from destructive bony lesions, leading to pain, fractures, mobility issues. Mm is preceded by an ageprogressive premalignant condition termed. Myeloma bone disease mbd is a devastating complication of multiple myeloma mm. Multiple myeloma is a cancer that develops in the bone marrow, the spongy tissue found in the center of most bones. Monoclonal gammopathies with lower values than above c. Multiple myeloma is a malignant disease characterized by plasmacytosis, paraprotein production, bone lesions, hypercalcemia, susceptibility to infections, and renal impairment. Epidemiology and pathophysiology of multiple myeloma.
Mar 15, 2017 epidemiology and pathophysiology multiple myeloma accounts for 1. Aug 01, 2017 this stage is termed smoldering multiple myeloma smm and it is generally defined on the basis of laboratory criteria. A metaanalysis found that using circulating micrornas had high sensitivity. Pathophysiology of multiple myeloma bone disease sciencedirect. Blimark c, holmberg e, mellqvist uh, landgren o, bjorkholm m, hultcrantz m, et al. Multiple myeloma early detection, diagnosis, and staging. Plasmacytomas are tumors, which typically form in the bone. Multiple myeloma mm is a plasma cell malignancy in which monoclonal plasma cells proliferate in bone marrow, resulting in an overabundance of monoclonal paraprotein m protein, destruction of bone, and displacement of other hematopoietic cell lines.
The signs and symptoms of myeloma vary with each person and stag. Read below for information about the causes, diagnosis, and treatment of multiple myeloma. You will find out more about body changes and other things that can signal a problem that may need medical care. Multiple myeloma plasma cells, which originate from postfollicular b cells, are characterised by complex. First described in 1848, mm is characterized by a proliferation of malignant plasma cells and a subsequent overabundance of monoclonal paraprotein m protein. Multiple myeloma is a rare type of cancer that affects bone marrow and alters your bloods plasma cells. Multiple myeloma and osteosarcoma combined account for. The immune system is impacted due to the inefficiency of the plasma cells to produce healthy antibodies, which fight infection.
This activity is accompanied by suppressed osteoblast differentiation and activity, resulting in severely impaired bone formation and development of devastating osteolytic lesions. Multiple myeloma hematology and oncology merck manuals. The pathophysiology of the disease is primarily related to four factors. Multiple myeloma is a form of cancer that affects bone marrow, the spongy soft tissue. Keywords multiple myeloma, mgus, plasma cell development, myeloma cancer stem cell, bone marrow microenvironment, myeloma oncogenomics. Epidemiology and pathophysiology multiple myeloma accounts for 1.
Disease overview multiple myeloma research foundation. For some types of cancer, risk factors are known for the majority of cases. These tests do not provide the same information as looking at the tumor itself. Subscribe to hematology news a metaanalysis found that using circulating micrornas had high sensitivity and specificity in the early diagnosis of multiple myeloma. There has been great progress in the development of therapies to treat multiple myeloma, and in survival rates for patients diagnosed with this cancer. Whether you or someone you love has cancer, knowing what to expect can help you cope. Multiple myeloma mm is a fatal, malignant bcell neoplasm characterized by uncontrolled, destructive growth of mutated plasma cells within the. First described in 1848, mm is part of a spectrum of diseases ranging from monoclonal gammopathy of unknown significance to plasma cell. It is characterized by a multifocal proliferation of clonal, longlived plasma cells within the bone marrow bm and associated skeletal destruction, serum monoclonal gammopathy, immune suppression, and endorgan sequelae. It typically affects the bones as the cancerous cells accumulate in a persons bone marrow. Prognosis and survival statistics for multiple myeloma the mmrf. Multiple myeloma is characterized by excess immunoglobulin protein production by plasma cells with. What is the pathophysiology of multiple myeloma mm. For understanding of the pathophysiology of multiple myeloma, features of the malignant clone and changes induced by the bonemarrow microenvironment are equally important.
1352 1553 1544 711 1033 1649 1661 546 1536 960 1224 1316 1096 420 284 499 1473 542 1580 1528 1655 658 392